Drug interactions
Clevidipine + Linagliptin-metformin
Severity: Minor
Clevidipine and Linagliptin-metformin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Calcium channel blockers can slightly impair insulin secretion and glucose tolerance. Clevidipine is given only short term by IV infusion, so any effect on glycemic control is small and transient.
What this interaction means in plain words
Clevidipine and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Clevidipine belongs to Cardiovascular; Linagliptin-metformin belongs to Endocrine.
Why it happens
Calcium channel blockade may mildly reduce insulin release, giving a weak pharmacodynamic opposition to antidiabetic drugs.
What to do
No dose change is needed; check blood glucose during prolonged infusion in patients with unstable diabetes.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Clevidipine and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Clevidipine
Frequently asked questions
Can I take Clevidipine with Linagliptin-metformin?
MediHelp rates the interaction as minor. Clevidipine and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Calcium channel blockers can slightly impair insulin secretion and glucose tolerance. Clevidipine is given only short term by IV infusion, so any effect on glycemic control is small and transient.
How serious is the interaction between Clevidipine and Linagliptin-metformin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; check blood glucose during prolonged infusion in patients with unstable diabetes.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
